Credit Suisse Starts Infinity Pharmaceutical (INFI) at Outperform
Tweet Send to a FriendGet Alerts INFI Hot Sheet
Price: $24.30 -0.25%
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade INFI Now!
Credit Suisse initiates coverage on Infinity Pharmaceutical (NASDAQ: INFI) with a Outperform. PT $42.00.
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $32.93 yesterday, with a 52 week range of $5.50-$37.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $32.93 yesterday, with a 52 week range of $5.50-$37.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
- Topeka Capital Starts Spansion (CODE) at Buy
- Topeka Capital Starts InvenSense (INVN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit Suisse
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
